A recent multinational retrospective study revealed that alopecia areata has a strong association with a heightened risk of psychiatric disorders, particularly among women. Adults diagnosed with alopecia areata face a notably increased likelihood of developing mental health conditions, with women being more susceptible to depression, anxiety, and eating disorders.
Following the COVID-19 pandemic, there was a sharp rise—up to 70%—in mental health issues, including suicide and eating disorders. Researchers observed that these adverse effects intensified after the pandemic, broadening their impact on various psychological outcomes.
"AA is linked to a significantly increased risk of developing psychiatric disorders, with women experiencing a greater overall burden. The impact of AA on mental health worsened after the COVID-19 pandemic, affecting multiple outcomes."
The study emphasized the need for routine, structured mental health screenings and prompt referrals in dermatology clinics, focusing on individuals at higher risk and those exposed to stressful life events.
This investigation was led by Katarzyna Łuczak from the Faculty of Medicine at Wrocław University of Science and Technology in Wrocław, Poland, and was published online on October 31, 2025, in the journal Dermatology and Therapy.
Researchers cautioned that relying solely on coded diagnoses for alopecia areata and psychiatric conditions could lead to misclassification. They also noted that the study did not include data on disease severity, socioeconomic variables, healthcare usage patterns, or family psychiatric history.
The study underscores how alopecia areata significantly affects mental well-being, especially in women, calling for integrated psychiatric screening within dermatological care.